Suchergebnisse - "Safra, Tamar"

PubPharm (8)

1

Liposome-encapsulated doxorubicin citrate (Myocet) for treatment of recurrent epithelial ovarian cancer : a retrospective analysis

enthalten in: Anti-cancer drugs | 2014

von Eitan, R. | Fishman, A. | Meirovitz, M. | +8

2

Phase II, open-label, randomized, multicenter study comparing the efficacy and safety of olaparib, a poly (ADP-ribose) polymerase inhibitor, and pegylated liposomal doxorubicin in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2012

von Kaye, S. | Lubinski, J. | Matulonis, U. | +13

CommentIn: J Clin Oncol. 2012 Feb 1;30(4):347-50. - PMID 22203759

3

Squamous cell carcinoma of the oral cavity in nonsmoking women : a new and unusual complication of chemotherapy for recurrent ovarian cancer?

enthalten in: The oncologist | 2012

von Cannon, T. | Lai, D. | Hirsch, D. | +7

4

BRCA mutation status and determinant of outcome in women with recurrent epithelial ovarian cancer treated with pegylated liposomal doxorubicin

enthalten in: Molecular cancer therapeutics | 2011

von Safra, T. | Borgato, L. | Nicoletto, M. | +11

5

Delayed neoplastic and renal complications in women receiving long-term chemotherapy for recurrent ovarian cancer

enthalten in: Journal of the National Cancer Institute | 2011

von Muggia, F. | Cannon, T. | Safra, T. | +1

6

Metastatic breast cancer : the role of pegylated liposomal doxorubicin after conventional anthracyclines

enthalten in: Cancer treatment reviews | 2008

von Verma, S. | Dent, S. | Chow, B. | +2

7

Herceptin (trastuzumab) : adjuvant and neoadjuvant trials

enthalten in: The Israel Medical Association journal : IMAJ | 2006

von Yaal-Hahoshen, N. | Safra, T.

8

Cardiac safety of liposomal anthracyclines

enthalten in: The oncologist | 2003

von Safra, T.

1
[1]